WXG-14621-31028
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 926 / CA
- Registered
- 2021-11-09
- Relationship
- Child or adolescent in my care
- Guardian
- 7S3-25773-16525
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-09
Registered in v-safe
-
2021-11-09
Dose 1 — Pfizer-BioNTech
- 2021-11-09
-
2021-11-10
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-11-11
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-12
-
2021-11-13
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-11-15
- 2021-11-17
- 2021-11-24
-
2021-11-30
Dose 2 — Pfizer-BioNTech
- 2021-11-30
- 2021-12-01
- 2021-12-02
-
2021-12-04
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-07
-
2021-12-14
Survey response — day 14, dose 2, dependentMedDRA: Rash papular — Feeling: Poor · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Raised, large rashMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Report sent to call center — day 14, dose 2, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-15
-
2021-12-17
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-30
- 2022-01-04
- 2022-01-11
- 2022-03-01
- 2022-05-31
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-09 | Pfizer-BioNTech | No |
| 2 | 2021-11-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-14 | Successful 2021-12-17 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — day 14, dose 2, dependent
Symptoms: Raised, large rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rash papular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release